検索結果 - Somnath Sarkar

  • 検索結果 1 - 8 結果 / 8
結果の絞り込み
  1. 1
    Addition of Bevacizumab to Fluorouracil-Based First-Line Treatment of Metastatic Colorectal Cancer: Pooled Analysis of Cohorts of Older Patients From Two Randomized Clinical Trials

    Addition of Bevacizumab to Fluorouracil-Based First-Line Treatment of Metastatic Colorectal Cancer: Pooled Analysis of Cohorts of Older Patients From Two Randomized Clinical Trials 著者: Fairooz F. Kabbinavar, Herbert I. Hurwitz, Jing Yi, Somnath Sarkar, Oliver Rosen

    出版事項 2008
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  2. 2
    Relationships Between Bone Mineral Density and Incident Vertebral Fracture Risk with Raloxifene Therapy

    Relationships Between Bone Mineral Density and Incident Vertebral Fracture Risk with Raloxifene Therapy 著者: Somnath Sarkar, Bruce Mitlak, Mayme Wong, John L. Stock, Dennis M. Black, Kristine D. Harper

    出版事項 2002
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  3. 3
    Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer

    Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer 著者: Fairooz F. Kabbinavar, Julie Hambleton, R. Mass, Herbert I. Hurwitz, Emily K. Bergsland, Somnath Sarkar

    出版事項 2005
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  4. 4
    Relationship Between Changes in Biochemical Markers of Bone Turnover and BMD to Predict Vertebral Fracture Risk

    Relationship Between Changes in Biochemical Markers of Bone Turnover and BMD to Predict Vertebral Fracture Risk 著者: Somnath Sarkar, Jean‐Yves Reginster, Gerald Crans, Adolfo Díez‐Pérez, Karen V. Pinette, Pierre D. Delmas

    出版事項 2004
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    Associations Between Baseline Risk Factors and Vertebral Fracture Risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study

    Associations Between Baseline Risk Factors and Vertebral Fracture Risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study 著者: Olof Johnell, John А. Kanis, Dennis M. Black, Á. Balogh, Gyula Poór, Somnath Sarkar, Chunmei Zhou, Imre Pávó

    出版事項 2004
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    Contribution of Raloxifene and Calcium and Vitamin D<sub>3</sub>Supplementation to the Increase of the Degree of Mineralization of Bone in Postmenopausal Women

    Contribution of Raloxifene and Calcium and Vitamin D<sub>3</sub>Supplementation to the Increase of the Degree of Mineralization of Bone in Postmenopausal Women 著者: G. Boivin, Paul Lips, Susan M. Ott, Kristine D. Harper, Somnath Sarkar, Karen V. Pinette, Pierre J. Meunier

    出版事項 2003
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    Response-Independent Survival Benefit in Metastatic Colorectal Cancer: A Comparative Analysis of N9741 and AVF2107

    Response-Independent Survival Benefit in Metastatic Colorectal Cancer: A Comparative Analysis of N9741 and AVF2107 著者: Axel Grothey, Eric Hedrick, R. Mass, Somnath Sarkar, Sam Suzuki, Ramesh K. Ramanathan, Herbert I. Hurwitz, Richard M. Goldberg, Daniel J. Sargent

    出版事項 2008
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial

    Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial 著者: Pierre D. Delmas, Kristine E. Ensrud, Jonathan D. Adachi, Kristine D. Harper, Somnath Sarkar, C. Gennari, Jean‐Yves Reginster, Huibert A. P. Pols, Robert R. Recker, Steven T. Harris, Wentao Wu, Harry K. Genant, Dennis M. Black, Richard Eastell

    出版事項 2002
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: